BackBioAffinity Technologies Overview

BioAffinity Technologies Current Cash

Latest current cash for BIAF: $2.4M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$2.43M
↑ 202.64% YoYΔ $1.63M vs prior year quarter

Peer trimmed avg / median

Loading

BioAffinity Technologies Current Cash History

Loading

BioAffinity Technologies vs. peers: Current Cash Comparison

Loading

BioAffinity Technologies Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioAffinity Technologies (BIAF) FAQ

BioAffinity Technologies (BIAF) currently reports a current cash of $2.4M as of June 2026. That compares with $800K in the prior-year period — up 202.6% year over year. Use the charts on this page to explore BioAffinity Technologies's current cash history and peer comparisons.

BioAffinity Technologies's current cash increased from $800K to $2.4M — a 202.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioAffinity Technologies reported $2.4M in current cash as of June 2026. That compares with $800K in the prior-year period — up 202.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $2.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioAffinity Technologies, and consider following BIAF for alerts when major investors trade the stock.